SARAH PEARCE: Open Payments
NPI 1285018879 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 39 payments from 19 companies in 2025. Trend: 2023 $519 · 2024 $726 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $126 |
| Merck Sharp & Dohme LLC | 4 | $120 |
| Novartis Pharmaceuticals Corporation | 4 | $97 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Geron Corporation | 2 | $58 |
| Daiichi Sankyo Inc. | 2 | $48 |
| Eisai Inc. | 2 | $45 |
| Astellas Pharma US Inc | 2 | $44 |
| TerSera Therapeutics LLC | 2 | $40 |
| BeiGene USA, Inc. | 1 | $33 |
Products named: KEYTRUDA, RYTELO, EMRELIS, DATROWAY, Lenvima, ELAHERE, BRUKINSA, Trodelvy.
Industry payments across NC — which companies pay providers there.
